The first Novavax vaccine doses are expected to arrive in Germany soon. Health Minister Karl Lauterbach gives new details and an exact date.
In Germany, part of the population is still not vaccinated against the corona virus. Many experts see this with concern, especially with regard to new variants such as Omikron. There is therefore great hope that the new EU-approved corona vaccine ‘Nuvaxovid’ from the US manufacturer Novavax will give the vaccination campaign a boost. The reason is that the vaccine is neither an mRNA nor a vector vaccine, but belongs to the group of protein vaccines.
Protein vaccines – such as the flu vaccine – have been used for a long time and are familiar to many people. The hope is therefore that one or the other unvaccinated person can still be persuaded to immunize against the corona virus. But what if the demand from February is greater than the stock of vaccine doses? HEIDELBERG24* reveals who should be vaccinated first after the Novavax delivery* in the service article just linked. * HEIDELBERG24 is part of IPPEN.MEDIA.
